A novel CRIg-targeted complement inhibitor protects cells from complement damage
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel CRIg-targeted complement inhibitor protects cells from complement damage
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 28, Issue 11, Pages 4986-4999
Publisher
FASEB
Online
2014-08-12
DOI
10.1096/fj.14-258046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
- (2014) Antonio M. Risitano et al. BLOOD
- Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome
- (2013) Gillian M. Keating DRUGS
- The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation
- (2013) K. Triantafilou et al. JOURNAL OF CELL SCIENCE
- An Engineered Construct Combining Complement Regulatory and Surface-Recognition Domains Represents a Minimal-Size Functional Factor H
- (2013) M. Hebecker et al. JOURNAL OF IMMUNOLOGY
- The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment
- (2012) A. M. Risitano et al. BLOOD
- The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: Review
- (2012) Ana Paula Alegretti et al. CELLULAR IMMUNOLOGY
- Sublytic C5b-9 Complexes Induce Apoptosis of Glomerular Mesangial Cells in Rats with Thy-1 Nephritis through Role of Interferon Regulatory Factor-1-dependent Caspase 8 Activation
- (2012) Lisha Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases
- (2011) M. Fridkis-Hareli et al. BLOOD
- A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement
- (2010) M. A. Lindorfer et al. BLOOD
- Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency
- (2010) Hongchang Qu et al. MOLECULAR IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Targeted Inhibition of the Complement Alternative Pathway with Complement Receptor 2 and Factor H Attenuates Collagen Antibody-Induced Arthritis in Mice
- (2009) N. K. Banda et al. JOURNAL OF IMMUNOLOGY
- A High-Affinity Inhibitor of Human CD59 Enhances Complement-Mediated Virolysis of HIV-1: Implications for Treatment of HIV-1/AIDS
- (2009) Weiguo Hu et al. JOURNAL OF IMMUNOLOGY
- Structure of complement fragment C3b–factor H and implications for host protection by complement regulators
- (2009) Jin Wu et al. NATURE IMMUNOLOGY
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
- The alternative complement pathway revisited
- (2008) Morten Harboe et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy
- (2008) X. Zhou et al. ONCOLOGIST
- Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-α,β on monocytes from patients with warm autoimmune hemolytic anemia
- (2008) Melca M.O. Barros et al. TRANSFUSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now